These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37387820)

  • 1. Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9830309. PubMed ID: 37387820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI.
    Xue L; Yuan X; Zhang S; Zhao X
    Evid Based Complement Alternat Med; 2021; 2021():9388562. PubMed ID: 34691230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Effects of Dapagliflozin in Combination with Metoprolol Sustained-Release Tablets on Prognosis and Cardiac Function in Patients with Acute Myocardial Infarction after PCI.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9838713. PubMed ID: 37416263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Effect of Dapagliflozin on Clinical Outcome after Drug-Eluting Stent Implantation in Elderly T2DM Patients: A Real-World Study.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9837890. PubMed ID: 38124908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function.
    Markers D
    Dis Markers; 2023; 2023():9807108. PubMed ID: 37387756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dapagliflozin on cardiac function indexes and serum MCP-1 levels in patients with Type 2 diabetes mellitus complicated with heart failure.
    Zhang X; Yang Y; Xiao W; Liu J; Zhang X; Chen K; Xiao W; Wang C
    Biotechnol Genet Eng Rev; 2023 Apr; ():1-13. PubMed ID: 37092853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of dapagliflozin-associated diabetic ketosis/ketoacidosis in patients with type 2 diabetes mellitus: A matched case-control study.
    Zhao Z; Zhao F; Zhang Y; Hu X; Li J; Tian C; Jin P; Liu D
    Diabetes Res Clin Pract; 2023 Feb; 196():110236. PubMed ID: 36610546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Dapagliflozin Ameliorates STZ-Induced Cardiac Hypertrophy in Type 2 Diabetic Rats by Inhibiting the Calpain-1 Expression and Nuclear Transfer of NF-
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9864038. PubMed ID: 38094410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Effect of Tegretol on Oxidative Stress, Serum Inflammatory Factors, and Left Ventricular Function in AMI Patients after Emergency PCI.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9783150. PubMed ID: 37811243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dapagliflozin on diabetic patients with cardiovascular disease via MAPK signalling pathway.
    Yue Z; Li L; Fu H; Yin Y; Du B; Wang F; Ding Y; Liu Y; Zhao R; Zhang Z; Yu S
    J Cell Mol Med; 2021 Aug; 25(15):7500-7512. PubMed ID: 34258872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway.
    International BR
    Biomed Res Int; 2023; 2023():9765065. PubMed ID: 37388370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Exploring the Effect of Dapagliflozin on Alcoholic Kidney Injury and Renal Interstitial Fibrosis in Rats Based on TIMP-1/MMP-24 Pathway.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9830542. PubMed ID: 37387937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are there sex differences in the effect of type 2 diabetes in the incidence and outcomes of myocardial infarction? A matched-pair analysis using hospital discharge data.
    Lopez-de-Andres A; Jimenez-Garcia R; Hernández-Barrera V; de Miguel-Yanes JM; Albaladejo-Vicente R; Villanueva-Orbaiz R; Carabantes-Alarcon D; Zamorano-Leon JJ; Lopez-Herranz M; de Miguel-Diez J
    Cardiovasc Diabetol; 2021 Apr; 20(1):81. PubMed ID: 33888124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Correlation between the Variability of Glycosylated Hemoglobin and Cardiovascular Risk in New-Onset T2DM Patients.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9785026. PubMed ID: 37810469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Efficacy of Dapagliflozin Combined with Lifestyle Intervention in Obesity Control.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9780164. PubMed ID: 38094412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does multivessel revascularization fit all patients with STEMI and multivessel coronary artery disease? A systematic review and meta-analysis.
    Hu MJ; Li XS; Jin C; Yang YJ
    Int J Cardiol Heart Vasc; 2021 Aug; 35():100813. PubMed ID: 34169144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoprotegerin levels change during STEMI and reflect cardiac function.
    Lindberg S; Jensen JS; Hoffmann S; Iversen AZ; Pedersen SH; Mogelvang R; Galatius S; Flyvbjerg A; Bjerre M
    Can J Cardiol; 2014 Dec; 30(12):1523-8. PubMed ID: 25475457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of emergency percutaneous coronary intervention on outcomes of ST-segment elevation myocardial infarction patients complicated by out-of-hospital cardiac arrest.
    Liu HW; Pan W; Wang LF; Sun YM; Li ZQ; Wang ZH
    Chin Med J (Engl); 2012 Apr; 125(8):1405-9. PubMed ID: 22613643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin.
    Avgerinos I; Liakos A; Tsapas A; Bekiari E
    Diabetes Metab Syndr Obes; 2019; 12():2549-2557. PubMed ID: 31819580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet indices in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Sus I; Hadadi L; Somkereki C; Dobreanu D
    Acta Endocrinol (Buchar); 2021; 17(4):543-547. PubMed ID: 35747852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.